Reason for request
- Re-assessment of Actual Benefit on the transparency Committee’s own initiative in accordance with article R 163-21 of the Social Security Code and changes to Summary of Product Characteristics.
Clinical Benefit
| Moderate |
The actual benefit of AETOXISCLEROL is moderate. |
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
7rXhrfrTFr4J86Tx
Listen
